Winch Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 509 |
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 556 |
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 569 |
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 488 |
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 469 |
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 455 |
|
2023
Q4 | $1 | Hold |
1
| – | – | ﹤0.01% | 439 |
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 462 |
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 455 |
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 450 |
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 441 |
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 447 |
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 495 |
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 496 |
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 511 |
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 524 |
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 509 |
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 478 |
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 468 |
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 422 |
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 407 |
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 392 |
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 383 |
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 444 |
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 480 |
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 405 |
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 375 |
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 358 |
|
2018
Q2 | $0 | Sell |
1
-5
| -83% | – | ﹤0.01% | 369 |
|
2018
Q1 | $1K | Sell |
6
-1
| -14% | -$167 | ﹤0.01% | 300 |
|
2017
Q4 | $2K | Sell |
7
-29
| -81% | -$8.29K | ﹤0.01% | 273 |
|
2017
Q3 | $13K | Buy |
36
+22
| +157% | +$7.94K | 0.01% | 155 |
|
2017
Q2 | $5K | Buy |
+14
| New | +$5K | ﹤0.01% | 223 |
|